Novel mesothelin-targeted chimeric antigen receptor-modified UNKT cells are highly effective in inhibiting tumor progression

The design of chimeric antigen receptors (CAR) significantly enhances the antitumor efficacy of T cells. Although some CAR-T products have been approved by FDA in treating hematological tumors, adoptive immune therapy still faces many difficulties and challenges in the treatment of solid tumors. In...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Wei Jiang (Autor), Guosheng Gu (Autor), Yumin Zhang (Autor), Yushuai Song (Autor), Ming Shi (Autor), Gang Wang (Autor), Huizhong Li (Autor), Tingting Tao (Autor), Jianhua Qin (Autor), Xianliang Li (Autor), Hongtao Jia (Autor), Feng Jiao (Autor), Weidong Xu (Autor), Xiaoyi Huang (Autor)
Formato: Libro
Publicado: Elsevier, 2023-11-01T00:00:00Z.
Materias:
Acceso en línea:Connect to this object online.
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

Connect to this object online.

3rd Floor Main Library

Detalle de Existencias desde 3rd Floor Main Library
Número de Clasificación: A1234.567
Copia 1 Disponible